Shanghai-based surgical robotics specialist, Ronovo Surgical, has reportedly raised over RMB 300 million (USD 41.3 million) in a Series B financing round. The funding round was co-led by Guolian Group and Ince Capital, with contributions from King Star Med LP and existing investor LongRiver. The capital will be utilized to drive the commercialization and global expansion of its flagship product, the Carina surgical robot.
Ronovo Surgical is known for its Carina laparoscopic surgery robot system, Carina laparoscopic imaging system, and Carina surgical instruments, among other product lines. The company holds over 100 patent filings both in China and internationally. Ronovo Surgical is also planning to establish a 12,000 sq.m. surgical robot plant, which will include a manufacturing center, clinical study center, clinical education center, and additional facilities.- Flcube.com
